Episode

Ep201: Jeremy Levin on Biotech in the Balance

Podcast: The Long Run with Luke Timmerman
Published: May 19, 2026
Duration seconds: 4120
Processing state: not_requested
Canonical source: https://soundcloud.com/longrunpodcast/ep201-jeremy-levin-on-biotech
Audio: https://feeds.soundcloud.com/stream/2323659545-longrunpodcast-ep201-jeremy-levin-on-biotech.mp3
JSON: /v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep201-jeremy-levin-on-biotech-in-the-balance
Markdown: /podcast/the-long-run-with-luke-timmerman-1124799/ep201-jeremy-levin-on-biotech-in-the-balance.md

Actions

POST https://stenobird.com/v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep201-jeremy-levin-on-biotech-in-the-balance/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799/ep201-jeremy-levin-on-biotech-in-the-balance.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Jeremy Levin, executive chair of Ovid Therapeutics, discusses his new book "Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust."